PPH News 60.27 06/04/2014 05:21:43 Pharmaceutical ETF Market

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pharmaceutical ETF Market Vectors (PPH) 60.27 $PPH

The Zacks Analyst Blog Highlights: Market Vectors Pharmaceutical ETF, Guggenheim S&P 500 Equal Weight Utilities ETF, First Trust ISE-Revere Natural Gas Index Fund and Canadian Solar
PR Newswire - Fri May 16, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Market Vectors Pharmaceutical ETF (AMEXPH-Free Report), Guggenheim S&P 500 Equal Weight Utilities ETF (AMEX:RYU-Free Report), First Trust ISE-Revere Natural Gas Index Fund (AMEX:FCG-Free Report), andCanadian Solar Inc. (Nasdaq:CSIQ-Free Report).

3 Non-Leveraged ETFs Beating SPY - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu May 15, 2:00PM CDT
These three ETFs have easily crushed SPY this year.

Pharma M&A Frenzy Pushing These ETFs Higher - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Wed Apr 23, 1:00PM CDT
The ongoing flurry of M&A talks in the pharma industry is sending the drug stocks and the related ETFs higher.

A Comprehensive Guide to Pharma ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Apr 15, 11:00AM CDT
Pharma ETFs look poised to deliver a strong performance this year.

March 2013 Distributions for Market Vectors Bank and Brokerage ETF and Market Vectors Pharmaceutical ETF
Business Wire - Thu Mar 28, 3:30PM CDT
The Market Vectors ETF Trust announced today the March 2013 distributions per share for the Market Vectors Bank and Brokerage ETF and Market Vectors Pharmaceutical ETF.

Daily ETF Roundup: Dow Nears 14,000 Level
Daniela Pylypczak - ETFDB - Tue Jan 29, 5:08PM CST
After yesterday’s pullback, investors welcomed several better-than-expected earnings reports, which helped outweigh sluggish economic data. Oil giant Valero (VLO) topped analysts expectations in their fourth quarter earnings report, posting...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Magna International's Impressive Quarterly Progress and Future Outlook

Updated Category News Views 285

Overview of Magna International's Second Quarter Results Magna International Inc. reported robust performance for the second quarter of 2025, showcasing resilience in the face of industry challenges. The company achieved $10.6 billion in sales, despite a 3% decline compared to the previous year, attributed mainly to lower light vehicle production in various markets....

Continue Reading
Mill Creek’s Desert Ridge Project Spurs Housing Growth

Updated Category News Views 19

Big Times for Desert Ridge with Modera City North Look alive, folks! There's movement on the horizon in Phoenix's Desert Ridge scene. Mill Creek Residential has kicked off the Modera City North project, aiming to inject 330 homes into this rapidly blossoming neighborhood. It's part of the City North master plan—spanning across 100 acres with two million square feet of...

Continue Reading
Stellantis Faces Lowest Italian Vehicle Production in Decades

Updated Category News Views 378

Stellantis and Its Production Challenges in Italy Stellantis (NYSE: STLA), the result of a major merger between iconic brands, is experiencing a notable decline in vehicle production within Italy. This setback is particularly concerning as it represents the lowest output levels this country has seen since 1956. Declining Production Figures Reported Recent data from union...

Continue Reading
Analyst Insights on Crocs Q3 Earnings and Future Trends

Updated Category News Views 242

Crocs Inc Earnings Analysis for Q3 BofA Securities analyst Christopher Nardone maintains a Buy rating on Crocs, Inc (NASDAQ: CROX) with an ambitious price target set at $179. This outlook highlights the optimism surrounding the company's financial prospects as it gears up to disclose its third-quarter results. Results Anticipation Investors eagerly await the announcement,...

Continue Reading
Opportunity for Investors Affected by Petco Securities Fraud

Updated Category News Views 239

Opportunity for Investors Affected by Petco Securities Fraud Investors who have experienced significant losses in Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) are presented with a crucial chance to engage in a securities fraud lawsuit. Faruqi & Faruqi, LLP, a respected name in securities litigation, is advocating for investors affected by these circumstances....

Continue Reading